Chief Scientific Officer
Dr. James Reynolds is a graduate of Queen’s University (B.Sc., 1982, Ph.D, 1987). His thesis research investigated the neurochemical mechanisms underlying heavy metal toxicity. Subsequently, he completed postdoctoral training at the Addiction Research Foundation and the University of Toronto. Dr. Reynolds’ first faculty position was at Memorial University in St. John’s, Newfoundland. He returned to Queen’s in 1995, where his research program has grown to encompass both basic and clinical investigations. Dr. Reynolds is a Full Professor in the Department of Biomedical and Molecular Sciences, and the Centre for Neuroscience Studies, at Queen’s University. His research interests over the past 20 years have centred around studies on the effects of alcohol on brain function. In particular, his current research program is focused on understanding the mechanisms of brain injury, and the resulting behavioural and cognitive deficits, that are induced by prenatal exposure to alcohol. The long term goal is to understand how prenatal exposure to alcohol alters brain neurochemistry and structure, and thus brain function, in offspring. Dr. Reynolds has been funded by CIHR for interdisciplinary basic and clinical investigations into the cellular mechanisms and neurobehavioural consequences of Fetal Alcohol Spectrum Disorder (FASD). He led a 7-member CIHR-funded New Emerging Team in FASD research, and served as the Interim Chief Scientific Officer and Project Lead for the FASD Demonstration Project with Kids Brain Health Network. On March 8, 2019, Dr. Reynolds was appointed Chief Scientific Officer of Kids Brain Health Network.
